AACR logo

More articles from Multigene Prognostic Signatures - Prognostic Factors and Biomarkers-- Clinical Testing and Validation

Identification of a Prognostic Signature Based on the Expression of Insulin-Related Genes in Early Breast Cancer.
A. Gennari, M. Sormani, A. Decensi, A. Decensi, P. Pronzato, V. Mirisola, M. Puntoni, M. Roncella, M. Ghilli, P. Bruzzi, U. Pfeffer

Cancer Research Dec 2009, 69 (24 Supplement) 108; DOI: 10.1158/0008-5472.SABCS-09-108
A Meta-Analysis of Gene Expression Profiling Studies Identifies Clinically Relevant Oncogenic Pathways in Basal-Like Breast Cancer.
M. Ignatiadis, P. Bedard, B. Haibe-Kains, B. Haibe-Kains, S. Singhal, S. Loi, C. Criscitiello, C. Desmedt, G. Bontempi, M. Piccart, M. Piccart, C. Sotiriou, C. Sotiriou

Cancer Research Dec 2009, 69 (24 Supplement) 106; DOI: 10.1158/0008-5472.SABCS-09-106
Limited Clinical Utility of Prognostic Gene Expression Profiles in Grade 3 Node-Negative Early Stage Breast Cancer.
P. Bedard, M. Ignatiadis, B. Haibe-Kains, B. Haibe-Kains, S. Loi, C. Criscitiello, C. Desmedt, G. Bontempi, M. Piccart, M. Piccart, C. Sotiriou, C. Sotiriou

Cancer Research Dec 2009, 69 (24 Supplement) 103; DOI: 10.1158/0008-5472.SABCS-09-103
Combining Genomic Profiling (70 Gene-Mammaprint) with Nodal Status Allows To Classify Patients with Primary Breast Cancer and Positive Lymph Nodes (1-9) into Very Distinct Prognostic Subgroups That Could Help Tailor Treatment Strategies.
M. Saghatchian, S. Mook, G. Pruneri, G. Viale, A. Glas, I. Eekhout, S. Delaloge, L. van 't Veer

Cancer Research Dec 2009, 69 (24 Supplement) 102; DOI: 10.1158/0008-5472.SABCS-09-102
The Molecular Anatomy of Breast Cancer Stroma; Independent Prognostic Role in ER-Positive and ER-Negative Cancers.
G. Bianchini, G. Bianchini, R. Alvarez, Y. Qi, C. Hatzis, T. Iwamoto, C. Shiang, C. Coutant, G. Hortobagyi, W. Symmans, L. Pusztai

Cancer Research Dec 2009, 69 (24 Supplement) 105; DOI: 10.1158/0008-5472.SABCS-09-105
Comparison of Prognostic Signatures in Node-Negative Tamoxifen-Treated Breast Cancer Patients.
V. Müller, M. Schmidt, A. Rody, K. Milde-Langosch, M. Kaufmann, H. Kölbl, F. Jänicke, K. Weber, M. Gehrmann

Cancer Research Dec 2009, 69 (24 Supplement) 104; DOI: 10.1158/0008-5472.SABCS-09-104
Evaluation of the Predictive Performance and Regimen Specificity of a 30-Gene Predictor of Pathologic Complete Response in a Prospective Randomized Neoadjuvant Clinical Trial for Stage I-III Breast Cancer.
A. Tabchy, W. Symmans, V. Valero, T. Vidaurre, A. Lluch, Y. Qi, E. Souchon, L. Barajas-Figueroa, H. Gomez, M. Martin, C. Coutant, K. Hess, G. Hortobagyi, L. Pusztai

Cancer Research Dec 2009, 69 (24 Supplement) 101; DOI: 10.1158/0008-5472.SABCS-09-101

Main menu

User menu

Search

More articles from Multigene Prognostic Signatures - Prognostic Factors and Biomarkers-- Clinical Testing and Validation

Articles

Info for

About Cancer Research